Your session is about to expire
← Back to Search
Semaglutide for Prediabetes
Study Summary
This trial will help researchers understand why some people respond better to the diabetes drug GLP-1 than others, which could lead to more personalized treatments for diabetes and related diseases.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 4 trial • 104 Patients • NCT04189848Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My blood sugar levels indicate I have prediabetes.I agree to use birth control during the study.I have a history of cancer.My family has a history of medullary thyroid cancer or MEN2.I have a serious heart, liver, pancreas, or kidney disease.I was hospitalized for COVID-19 in the last 3 months.I am 18 years old or older.I have been diagnosed with diabetes.I have recently used diabetes or steroid medications.I am at high risk for diabetes due to obesity or unhealthy metabolism.Your blood and kidney function test results need to be within certain normal ranges.I have a history of pancreatitis, medullary thyroid cancer, or MEN 2.I am 18 years old or older.You have had a severe allergic reaction to the study medication or any similar medications in the past.
- Group 1: Semaglutide
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is Semaglutide currently certified by the FDA?
"The safety of semaglutide is rated a 3, as this is a Phase 4 trial demonstrating the treatment's approval."
How many individuals are enrolling in this trial?
"Affirmative, the clinical trial is presently recruiting patients as per information displayed on clinicaltrials.gov. This research project was advertised on November 22nd 2021 and last updated on March 15th 2022. Its goal is to recruit 300 individuals from 1 site for assessment purposes."
Has recruitment for this study already begun?
"The clinicaltrials.gov website confirms that this medical trial is currently looking for individuals to join, with the original posting date being November 22nd 2021 and an update on March 15th 2022."
What are the underlying objectives of this experiment?
"The primary goal of this medical trial is to assess Insulin Sensitivity over a 12 week period. Additionally, the Mean change in insulin Area Under the Curve (AUC), glucose AUC, and C-peptide AUC will be evaluated as Secondary Outcomes based on pre and post drug intervention data."
What afflictions can be ameliorated through Semaglutide treatment?
"Semaglutide can be a viable treatment option for long-term weight management, dietary restriction of caloric intake, and the promotion of physical activity."
Is this a pioneering clinical trial?
"At present, the drug Semaglutide is being tested in 58 extant clinical trials across 772 cities and 55 nations. Novo Nordisk A/S began researching this treatment back in 2018 with a Phase 4 study involving 1387 patients; since then, 124 studies have been conducted."
Has there been additional research conducted on Semaglutide?
"Currently, there are 58 clinical trials for Semaglutide in progress. 27 of these studies are classified as Phase 3 and the majority take place at Loma Linda, California; however, 3907 other medical research centres across the globe have enrolled patients to test this particular drug."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger